"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Ozempic mimics the GLP-1 hormone the body naturally produces after eating, suppressing appetite and stimulating weight loss.

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

Early studies show a drug can effectively 'switch on' particular cells within the nervous system that play an important role ...

DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global ...

Hims & Hers (HIMS) is launching a new GLP-1 tracker in its ... diabetes drug Mounjaro and weight-loss drug Zepbound, off its ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

GLP-1s seem to be everywhere. The appetite suppressant drugs, with brand names like Ozempic and Wegovy, have grown in ...

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...